Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi Center Two Part Study to Evaluate the Efficacy and Safety of NMN as an Anti-ageing Supplement in Middle Aged and Older (40-65 Years) Adults

NCT04823260 is registered in ClinicalTrials.gov with Abinopharm, Inc as lead sponsor.

NCT NCT04823260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04823260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi Center Two Part Study to Evaluate the Efficacy and Safety of NMN as an Anti-ageing Supplement in Middle Aged and Older (40-65 Years) Adults
Lead sponsor
Abinopharm, Inc
Phase
Not applicable
Overall status
Completed
Start date
May 25, 2021
Completion date
September 9, 2021
Enrollment
90 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aging